Identification of gene fusions from human lung cancer mass spectrometry data

BMC Genomics

Volumn 14, Issue SUPP 8, 2013, Pages

  Sun, Han ^a,b   Xing, Xiaobin ^c   Li, Jing ^b   Zhou, Fengli ^d   Chen, Yunqin ^b   He, Ying ^a,b   Li, Wei ^b   Wei, Guangwu ^a   Chang, Xiao ^e   Jia, Jia ^b   Li, Yixue ^a,b   Xie, Lu ^a,b  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b SHANGHAI CENTER FOR BIOINFORMATION TECHNOLOGY   (China)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^d THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; MYH9 ALK FUSION PEPTIDE; SPLICING PEPTIDE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; DNA SEQUENCE; EXON; FALSE POSITIVE RESULT; FUSION GENE; GENE FUSION; GENETIC LINKAGE; GENOMICS; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MYH9 ALK FUSION GENE; PEPTIDE ANALYSIS; PROTEIN DATABASE; PROTEOMICS; QUALITY CONTROL; RELIABILITY; RNA SEQUENCE; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

ALTERNATIVE SPLICING; CARCINOMA, NON-SMALL-CELL LUNG; DATABASES, GENETIC; GENE FUSION; HUMANS; LUNG; LUNG NEOPLASMS; ONCOGENE FUSION; ONCOGENE PROTEINS, FUSION; PEPTIDES; RECOMBINANT FUSION PROTEINS; TANDEM MASS SPECTROMETRY;

EID: 84889684698     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-S8-S5     Document Type: Article

References (42)

1. Stratton MR, Campbell PJ, PA. Futreal, The cancer genome. Nature 2009, 458(7239):719-24. 10.1038/nature07943, 2821689, 19360079.
2. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001, 29(1):308-11. 10.1093/nar/29.1.308, 29783, 11125122.
3. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, Teaque JW, Campbell PJ, Stratton MR, Futreal PA. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 2011, 39(Database):D945-50. 10.1093/nar/gkq929, 3013785, 20952405.
4. Li J, Su Z, Ma ZQ, Slebos RJ, Halvey P, Tabb DL, Liebler DC, Pao W, Zhang B. A bioinformatics workflow for variant peptide detection in shotgun proteomics. Mol Cell Proteomics 2011, 10(5):M110 006536. 3098595, 21389108.
5. Wang XJ, Slebos RJ, Wang D, Halvey PJ, Tabb DL, Liebler DC, Zhang B. Protein Identification Using Customized Protein Sequence Databases Derived from RNA-Seq Data (vol 11, pg 1009, 2012). Journal of Proteome Research 2012, 11(9):4764-4764. 10.1021/pr300713g, 3727138, 22103967.
6. Castellana N, Bafna V. Proteogenomics to discover the full coding content of genomes: A computational perspective. Journal of Proteomics 2010, 73(11):2124-2135. 10.1016/j.jprot.2010.06.007, 2949459, 20620248.
7. Tanner S, Shen Z, Ng J, Florea L, Guigó R, Briggs S, Bafna V. Improving gene annotation using peptide mass spectrometry. Genome Research 2007, 17(2):231-239. 10.1101/gr.5646507, 1781355, 17189379.
8. Xing XB, Li QR, Sun H, Fu X, Zhan F, Huang X, Li J, Chen C, Shyr Y, Zeng R, Li YX, Xie L. The discovery of novel protein-coding features in mouse genome based on mass spectrometry data. Genomics 2011, 98(5):343-351. 10.1016/j.ygeno.2011.07.005, 21840390.
9. Castellana NE, Payne SH, Shen Z, Stanke M, Bafna V, Briggs SP. Discovery and revision of Arabidopsis genes by proteogenomics. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(52):21034-21038. 10.1073/pnas.0811066106, 2605632, 19098097.
10. Gupta N, Benhamida J, Bhargava V, Goodman D, Kain E, Kerman I, Nguyen N, Ollikainen N, Rodriguez J, Wang J, Lipton MS, Romine M, Bafna V, Smith RD, Pevzner PA. Comparative proteogenomics: Combining mass spectrometry and comparative genomics to analyze multiple genomes. Genome Research 2008, 18(7):1133-1142. 10.1101/gr.074344.107, 2493402, 18426904.
11. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127(12):2893-917. 10.1002/ijc.25516, 21351269.
12. Lee W, Jiang Z, Liu J, Haverty PM, Guan Y, Stinson J, Yue P, Zhang Y, Pant KP, Bhatt D, Ha C, Johnson S, Kennemer MI, Mohan S, Nazarenko I, Watanabe C, Sparks AB, Shames DS, Gentleman R, de Sauvage FJ, et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 2010, 465(7297):473-477. 10.1038/nature09004, 20505728.
13. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, Bando M, Ohno S, Ishikawa Y, Aburatani H, Niki T, Sohara Y, Sugiyama Y, Mano H, Shames DS. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448(7153):561-U3. 10.1038/nature05945, 17625570.
14. Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, Nardone J, Lee K, Reeves C, Li Y, Hu Y, Tan Z, Stokes M, Sullivan L, Mitchell J, Wetzel R, MacNeill J, Ren JM, Yuan J, Bakalarski CE, Villen J, Kornhauser JM, Smith B, Li B, Zhou X, Gygi SP, Gu TL, Polakiewicz RD, Rush J, Comb MJ. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007, 131(6):1190-203. 10.1016/j.cell.2007.11.025, 18083107.
15. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. A census of human cancer genes. Nat Rev Cancer 2004, 4(3):177-83. 10.1038/nrc1299, 2665285, 14993899.
16. Kim P, Yoon S, Kim N, Lee S, Ko M, Lee H, Kang H, Kim J, Lee S. ChimerDB 2.0-a knowledgebase for fusion genes updated. Nucleic Acids Research 2010, 38:D81-D85. 10.1093/nar/gkp982, 2808913, 19906715.
17. Flicek P, Amode MR, Barrell D, Beal K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fairley S, Fitzgerald S, Gil L, Gordon L, Hendrix M, Hourlier T, Johnson N, Kähäri AK, Keefe D, Keenan S, Kinsella R, Komorowska M, Koscielny G, Kulesha E, Larsson P, Longden I, McLaren W, Muffato M, Overduin B, Pignatelli M, Pritchard B, Riat HS, et al. Ensembl 2012. Nucleic Acids Res 2012, 40(Database):D84-90. 3245178, 22086963.
18. Smith BE, Hill JA, Gjukich MA, Andrews PC. Tranche distributed repository and ProteomeCommons.org. Methods Mol Biol 2011, 696:123-45. 10.1007/978-1-60761-987-1_8, 21063945.
19. Kessner D, Chambers M, Burke R, Agus D, Mallick P. ProteoWizard: open source software for rapid proteomics tools development. Bioinformatics 2008, 24(21):2534-2536. 10.1093/bioinformatics/btn323, 2732273, 18606607.
20. Craig R, Beavis RC. TANDEM: matching proteins with tandem mass spectra. Bioinformatics 2004, 20(9):1466-7. 10.1093/bioinformatics/bth092, 14976030.
21. Geer LY, Markey SP, Kowalak JA, Wagner L, Xu M, Maynard DM, Yang X, Shi W, Bryant SH. Open mass spectrometry search algorithm. Journal of Proteome Research 2004, 3(5):958-964. 10.1021/pr0499491, 15473683.
22. Kunishima S, Matsushita T, Kojima T, Amemiya N, Choi YM, Hosaka N, Inoue M, Jung Y, Mamiya S, Matsumoto K, Miyajima Y, Zhang G, Ruan C, Saito K, Song KS, Yoon HJ, Kamiya T, Saito H. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions. J Hum Genet 2001, 46(12):722-9. 10.1007/s100380170007, 11776386.
23. Seri M, Pecci A, Di Bari F, Cusano R, Savino M, Panza E, Nigro A, Noris P, Gangarossa S, Rocca B, Gresele P, Bizzaro N, Malatesta P, Koivisto PA, Longo I, Musso R, Pecoraro C, Iolascon A, Magrini U, Rodriguez Soriano J, Renieri A, Ghiggeri GM, Ravazzolo R, Balduini CL, Savoia A. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 2003, 82(3):203-15.
24. Ma ZG, Hill DA, Collins MH, Morris SW, Sumegi J, Zhou M, Zuppan C, Bridge JA. Fusion of ALK to the ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes & Cancer 2003, 37(1):98-105. 10.1002/gcc.10177, 12661011.
25. Lawrence B, Perez-Atayde A, Hibbard MK, Rubin BP, Dal Cin P, Pinkus JL, Pinkus GS, Xiao S, Yi ES, Fletcher CD, Fletcher JA. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. American Journal of Pathology 2000, 157(2):377-384. 10.1016/S0002-9440(10)64550-6, 1850130, 10934142.
26. Damm-Welk C, Klapper W, Oschlies I, Gesk S, Röttgers S, Bradtke J, Siebert R, Reiter A, Woessmann W. Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation. British Journal of Haematology 2009, 146(3):306-309. 10.1111/j.1365-2141.2009.07754.x, 19545284.
27. Colleoni GWB, Bridge JA, Garicochea B, Liu J, Filippa DA, Ladanyi M. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35). American Journal of Pathology 2000, 156(3):781-789. 10.1016/S0002-9440(10)64945-0, 1876849, 10702393.
28. Hernandez L, Beà S, Bellosillo B, Pinyol M, Falini B, Carbone A, Ott G, Rosenwald A, Fernández A, Pulford K, Mason D, Morris SW, Santos E, Campo E. Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas - Identification of a new TFG-ALK(XL) chimeric gene with transforming activity. American Journal of Pathology 2002, 160(4):1487-1494. 10.1016/S0002-9440(10)62574-6, 1867210, 11943732.
29. Elenitoba-Johnson KSJ, Crockett DK, Schumacher J, Jenson S, Coffin C, Rockwood A, Lim M. Proteomic identification of oncogenic chromosomal translocation partners encoding chimeric anaplastic lymphoma kinase fusion proteins. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(19):7402-7407. 10.1073/pnas.0506514103, 1464352, 16651537.
30. Lamant L, Gascoyne RD, Duplantier MM, Armstrong F, Raghab A, Chhanabhai M, Rajcan-Separovic E, Raghab J, Delsol G, Espinos E. Non-muscle myosin heavy chain (MYH9): A new partner fused to ALK in anaplastic large cell lymphoma. Genes Chromosomes & Cancer 2003, 37(4):427-432. 10.1002/gcc.10232, 12800156.
31. Gupta N, Tanner S, Jaitly N, Adkins JN, Lipton M, Edwards R, Romine M, Osterman A, Bafna V, Smith RD, Pezvner PA. Whole proteome analysis of post-translational modifications: applications of mass-spectrometry for proteogenomic annotation. Genome Res 2007, 17(9):1362-77. 10.1101/gr.6427907, 1950905, 17690205.
32. Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nature Biotechnology 2008, 26(12):1367-1372. 10.1038/nbt.1511, 19029910.
33. Eng JK, Mccormack AL, Yates JR. An Approach to Correlate Tandem Mass-Spectral Data of Peptides with Amino-Acid-Sequences in a Protein Database. Journal of the American Society for Mass Spectrometry 1994, 5(11):976-989. 10.1016/1044-0305(94)80016-2, 24226387.
34. Perkins DN, Pappin DJ, Creasy BM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20(18):3551-3567. 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2, 10612281.
35. Zhang J, Xin L, Shan B, Chen W, Xie M, Yuen D, Zhang W, Zhang Z, Lajoie G, Ma B. PEAKS DB: De Novo Sequencing Assisted Database Search for Sensitive and Accurate Peptide Identification. Molecular & Cellular Proteomics 2012, 11(4). 3322562, 22186715.
36. Chi H, Sun RX, Yang B, Song CQ, Wang LH, Liu C, Fu Y, Yuan ZF, Wang HP, He SM, Dong MQ. pNovo: De novo Peptide Sequencing and Identification Using HCD Spectra. Journal of Proteome Research 2010, 9(5):2713-2724. 10.1021/pr100182k, 20329752.
37. Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 2007, 7(4):233-45. 10.1038/nrc2091, 17361217.
38. Nagaraj N, Wisniewski J, Geiger T, Cox J, Kircher M, Kelso J, Pääbo S, Mann M. Deep proteome and transcriptome mapping of a human cancer cell line. Molecular Systems Biology 2011, 7. 3261714, 22068331.
39. Blakeley P, Overton IM, Hubbard SJ. Addressing Statistical Biases in Nucleotide-Derived Protein Databases for Proteogenomic Search Strategies. Journal of Proteome Research 2012, 11(11):5221-5234. 10.1021/pr300411q, 3703792, 23025403.
40. Ng J, Pevzner PA. Algorithm for identification of fusion proteins via mass spectrometry. Journal of Proteome Research 2008, 7(1):89-95. 10.1021/pr070214g, 18173219.
41. Kikuchi T, Hassanein M, Amann JM, Liu Q, Slebos RJ, Rahman SM, Kaufman JM, Zhang X, Hoeksema MD, Harris BK, Li M, Shyr Y, Gonzalez AL, Zimmerman LJ, Liebler DC, Massion PP, Carbone DP. In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers. Mol Cell Proteomics 2012, 11(10):916-32. 10.1074/mcp.M111.015370, 3494148, 22761400.
42. Magrane M, Consortium U. UniProt Knowledgebase: a hub of integrated protein data. Database-the Journal of Biological Databases and Curation 2011, 3070428, 21447597.